Future studies of the precise regulatory mechanisms involved, such as NF-κB inhibition or ILC3 expansion (13, 40) and why these were insufficient to mitigate arthritis in ASF-SKG mice, will be important for development of precision probiotics or other ileal immunomodulators in SpA. The gene discussed is NFKB1; the disease is arthritic joint disease.